Therapeutic plasma exchange performed in tandem with hemodialysis for patients with M-protein disorders
- 1 July 2006
- journal article
- case report
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 21 (2), 100-104
- https://doi.org/10.1002/jca.20068
Abstract
M‐proteins are monoclonal immunoglobulins or immunoglobulin fragments that aberrantly accumulate in the plasma. Hemodialysis (HD) patients with M‐proteins may, under certain circumstances, also need therapeutic plasma exchange (TPE). We employed a protocol for tandem TPE/HD in patients with M‐protein disorders. We followed the urea reduction ratio (URR), a measure of the efficiency of HD, to compare the effect of TPE on HD efficiency during tandem procedures versus the efficiency of HD performed as a stand‐alone procedure in the same patients. Three men (J.M., R.T., M.M.) underwent 23, 80, and 25 tandem TPE/HD over 3, 17, and 7 months, respectively, almost all in the outpatient setting. Mean whole blood flow rate (in ml/min) was slower during hemodialysis alone than during TPE/HD for J.M. (289 ± 24 vs. 332 ± 22, P < 0.0001) and R.T. (310 ± 20 vs. 367 ± 15, P < 0.0001) but not for M.M. (395 ± 65 vs. 404 ± 62, P = 0.6844). URR was equivalent during hemodialysis alone and during TPE/HD for J.M. (54 ± 4.2 vs. 58 ± 1.4, P = 0.3333), R.T. (69 ± 4.9 vs. 70 ± 2.5, P = 0.9804), and M.M. (71 ± 2.4 vs. 67 ± 1.5, P = 0.1143). J.M.'s renal function recovered sufficiently to permit discontinuation of hemodialysis. R.T. experienced both subjective and objective improvement of his arthritic symptoms. M.M. achieved hemostatic control but ultimately died of amyloidosis. TPE/HD is feasible using disparate pieces of equipment when the therapeutic plasma exchange circuit is connected in parallel with the low‐pressure side of the hemodialysis circuit. Our experience illustrates that therapeutic plasma exchange did not adversely impact hemodialysis when the two procedures were performed in tandem. J. Clin. Apheresis 2005.Keywords
This publication has 15 references indexed in Scilit:
- I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: Update 2000American Journal of Kidney Diseases, 2001
- Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluidJournal of Clinical Apheresis, 1996
- Plasma Cell DyscrasiasPublished by American Medical Association (AMA) ,1992
- Analysis of venous access for therapeutic plasma exchange in patients with neurological diseaseJournal of Clinical Apheresis, 1992
- Treatment of Renal Failure Associated With Multiple MyelomaArchives of Internal Medicine, 1990
- Long-term use of antecubital veins for plasma exchange. The Canadian Cooperative Multiple Sclerosis Study GroupTransfusion, 1989
- Controlled plasma exchange trial in acute renal failure due to multiple myelomaKidney International, 1988
- Management of Myeloma Kidney: An Anti-Light-Chain ApproachAmerican Journal of Kidney Diseases, 1987
- Plasmapheresis in the treatment of acute renal failure in multiple myelomaAmerican Journal Of Medicine, 1979
- Successful treatment of myeloma kidney by diuresis and plasmaphoresis.BMJ, 1976